Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Research finds insecticide danger
Imidacloprid causes impact to bee genes, say scientists

A study has revealed that the genes of honeybees are affected by exposure to neonicotinoid insecticides.

Researchers were able to identify that just two parts per billion of the insecticide imidacloprid was strong enough to impact on the activity of honeybee genes.

The findings follow the European Commission's decision to temporarily ban the use of three neonicotinoids back in April 2013, due to concerns they could be linked to bee deaths.

Dr Reinhard Stöger, an associate professor in epigenetic at the University of Nottingham's School of Biosciences, led the study.

He said: "Although larvae can still grow and develop in the presence of imidacloprid, the stability of the developmental process appears to be compromised."

Dr Stöger also added that, should the bees be exposed to additional stresses, such as pests, disease and bad weather, it is likely to increase the rate of developmental failure.

The results support the European Food Safety Authority's (EFSA) January 2013 report, which deemed imidacloprid an "unacceptable" danger to bees.

Transient Exposure to Low Levels of Insecticide Affects Metabolic Networks of Honeybee Larvae has been published in the Public Library Of Science (PLOS) ONE journal.

The study was funded by the Co-operative Group under its Plan Bee campaign.

Related News

EU takes steps to protect bees
Insecticide danger to bees addressed

 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'